Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
134 Results for "
IMP
" in MedChemExpress (MCE) Product Catalog:
Products (134)
134 Results for "IMP" in MCE Product Catalog:
Cat. No.: HY-RS06794
Target:
Research Areas:
IMP4 Human Pre-designed siRNA Set A contains three designed siRNAs for IMP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS24431
Target:
Research Areas:
Imp3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Imp3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-108213S1
Purity: ≥98.0%
Synonyms: 5'-IMP-15N4 dilithium; IMP-15N4 dilithium; Inosine 5'-dihydrogen phosphate-15N4 dilithium
Cat. No.: HY-W769319
Synonyms: 5'-IMP-13C5; IMP-13C5; Inosine 5'-dihydrogen phosphate-13C5
Cat. No.: HY-137450A
CAS No.: 1401683-39-3
Synonyms: IMP4297 hydrochloride; JS109 hydrochloride
Senaparib hydrochloride (IMP4297 hydrochloride) is an oral, selective PARP1/2 inhibitor with potent anti-tumor activity. Senaparib hydrochloride shows antitumor activity against advanced ovarian cancer .
Cat. No.: HY-10250A
Purity: 99.82%
Synonyms: TCN-P sodium
Target:
Research Areas:
Triciribine phosphate sodium inhibits amidophosphoribosyltransferase by an allosteric mechanism which affects the first committed step of de novo purine biosynthesis. Triciribine phosphate sodium also inhibits IMP dehydrogenase which is the first committed step of guanosine nucleotide synthesis. Tricilibine phosphate does not affect ligase activity .
Cat. No.: HY-108213AR
CAS No.: 352195-40-5
Synonyms: 5'-IMP disodiumhydrate(1:2:X) (Standard); IMP disodiumhydrate(1:2:X) (Standard); Inosine 5'-(dihydrogen phosphate) disodiumhydrate(1:2:X) (Standard)
Cat. No.: HY-175489
CAS No.: 1770826-25-9
Target:
Research Areas:
D-CS319 is a potent inhibitor of metallo-𝛽-lactamases (MBLs) with IC50 values of 2.0 and 3.0 μM for IMP-1 and IMP-78, respectively. D-CS319 has antibacterial activity .
Cat. No.: HY-RS06795
Target:
Research Areas:
IMPA1 Human Pre-designed siRNA Set A contains three designed siRNAs for IMPA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS01591
Target:
Research Areas:
BRAP Human Pre-designed siRNA Set A contains three designed siRNAs for BRAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-152105
CAS No.: 1802363-75-2
Target:
Research Areas:
Metallo-β-lactamase-IN-9 (Compound 23) is a pan metallo-beta-lactamase (MBL) inhibitor with IC50s of 35, 269 and 369 nM against NDM-1, VIM-1 and IMP-1, respectively .
Cat. No.: HY-161310
CAS No.: 1804934-57-3
Target:
Research Areas:
Metallo-β-lactamase-IN-15 (Compound ±13) is a potent MBL inhibitor, the IC50 values for NDM-1、IMP-1 and VIM-2 were 0.29 μM, 0.088 μM and 0.063 μM, respectively .
Cat. No.: HY-144259
CAS No.: 1501705-61-8
Target:
Research Areas:
Metallo-β-lactamase-IN-4 (compound 40) is a potent metallo-β-lactamases (MBL) inhibitor, with IC50 values of 0.1 μM (VIM-1), 1.3 μM (NDM-1), and 5.0 μM (IMP-7), respectively .
Cat. No.: HY-144262
CAS No.: 2711044-25-4
Target:
Research Areas:
Metallo-β-lactamase-IN-4 (compound 40) is a potent metallo-β-lactamases (MBL) inhibitor, with IC50 values of 0.5 μM (VIM-1), 2.1 μM (NDM-1), and 3.3 μM (IMP-7), respectively .
Cat. No.: HY-128049
CAS No.: 1212185-26-6
Target:
Research Areas:
ML121 is a selective and potent VIM-2 inhibitor with an IC50 of 54 nM and a Ki of 148 nM. ML121 shows inactive in IMP-1 and TEM-1 beta-lactamase assays. ML121 can potentiate the antibiotic activity of Imipenem (HY-B1369A) in VIM-2 transformed E.coli .
Cat. No.: HY-131391
CAS No.: 66622-47-7
Target:
Research Areas:
m-Isobutyl Ibuprofen (Compound IMP-A) is the impurity found during synthesis of Ibuprofen (HY-78131) .
Cat. No.: HY-144261
CAS No.: 128294-71-3
Target:
Research Areas:
Metallo-β-lactamase-IN-3 (compound 35) is a potent metallo-β-lactamases (MBL) inhibitor. Metallo-β-lactamase-IN-3 shows high activity against VIM-1 and NDM-1, with IC50 of 0.6 and 1.0 μM, respectively. Metallo-β-lactamase-IN-3 does not show inhibition of IMP-7 .
Cat. No.: HY-155201
CAS No.: 3035446-91-1
YJ182 is a NDM-1 inhibitor (IC50: 0.23 μM). YJ182 also inhibits IMP-1, VIM-2, GIM-1, and MMP-2, with IC50s of 0.25, 0.61, 0.49, and 6.92 μM respectively. YJ182 can be used for bacterial infection research .
Cat. No.: HY-146165
CAS No.: 1610537-25-1
Target:
Research Areas:
Metallo-β-lactamase-IN-8 (compound 17) is a potent, reversible and competitive broad-spectrum inhibitor of metallo-β-lactamases (MβLs), with IC50s of 1.3 μM, 5.7 μM, 9.8 μM, and 9.9 μM for L1, ImiS, IMP-1 and VIM-2, respectively. Metallo-β-lactamase-IN-8 exhibits antibacterial activity .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
